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Abstract
The existence of loss and gain of chromosomes, known as aneuploidy, has been previously described within the central
nervous system. During development, at least one-third of neural progenitor cells (NPCs) are aneuploid. Notably, aneuploid
NPCs may survive and functionally integrate into the mature neural circuitry. Given the unanswered significance of this
phenomenon, we tested the hypothesis that neural differentiation induced by all-trans retinoic acid (RA) in pluripotent stem
cells is accompanied by increased levels of aneuploidy, as previously described for cortical NPCs in vivo. In this work we used
embryonal carcinoma (EC) cells, embryonic stem (ES) cells and induced pluripotent stem (iPS) cells undergoing
differentiation into NPCs. Ploidy analysis revealed a 2-fold increase in the rate of aneuploidy, with the prevalence of
chromosome loss in RA primed stem cells when compared to naı ¨ve cells. In an attempt to understand the basis of
neurogenic aneuploidy, micronuclei formation and survivin expression was assessed in pluripotent stem cells exposed to
RA. RA increased micronuclei occurrence by almost 2-fold while decreased survivin expression by 50%, indicating possible
mechanisms by which stem cells lose their chromosomes during neural differentiation. DNA fragmentation analysis
demonstrated no increase in apoptosis on embryoid bodies treated with RA, indicating that cell death is not the mandatory
fate of aneuploid NPCs derived from pluripotent cells. In order to exclude that the increase in aneuploidy was a spurious
consequence of RA treatment, not related to neurogenesis, mouse embryonic fibroblasts were treated with RA under the
same conditions and no alterations in chromosome gain or loss were observed. These findings indicate a correlation
amongst neural differentiation, aneuploidy, micronuclei formation and survivin downregulation in pluripotent stem cells
exposed to RA, providing evidence that somatically generated chromosomal variation accompanies neurogenesis in vitro.
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Introduction
Pluripotent stem cells, as capable of forming any cell type in the
body, have been extensively used to study developmental biology,
including neurogenesis. In the beginning, embryonal carcinoma
(EC) cells were the unique choice for analyzing differentiation in
vitro [1]. With the isolation of embryonic stem (ES) cells [2] and
more recently, induced pluripotent stem (iPS) cells derived from
reprogrammed somatic cells [3,4,5], new tools for studying the
stemness behavior and the ability to differentiate into neurons
became available.
The all-trans retinoic acid (RA) is a metabolic compound derived
from vitamin A, widely associated with neurogenesis [6]. During
embryogenesis, RA contributes to patterning of the neural plate
and neural tube [7,8,9]. In adulthood, it plays a role in neuronal
differentiation within the dentate gyrus [10], in the maintenance of
motor neurons [11] and in mammalian nerve regeneration [12].
Indeed, RA is the most used morphogen to produce neural
progenitor cells (NPCs) and neurons from stem cells in vitro
[13,14,15,16].
The existence of variations in chromosome number (aneuploidy)
in NPCs and neurons from mice, fish and humans has been
previously described [17,18,19]. Aneuploid NPCs are present at a
substantial rate of 33% in the developing brain [18,20,21] and 20%
in the cerebellum [22]. Also, aneuploid neurons can be found
functionally integrated into the neural circuitry of adults [21,23].
Even though the significance of aneuploidy within the nervous
system is still unknown, the brain is a mosaic composed by euploid
and aneuploid cells,whichmaycontribute for braincomplexity [18].
Despite chromosomal mosaicism has been extensively described
within the brain in vivo, possible causes of aneuploidy during
development of the central nervous system (CNS) have never been
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e20667explored. Here, we asked whether neurogenesis triggered by RA in
vitro is accompanied by aneuploidy in pluripotent stem cell types.
Materials and Methods
Reprogramming into pluripotent stem cells
Induced pluripotent stem (iPS) cells were developed in house
[24] as previously described by Takahashi and Yamanaka [3]. The
procedures were according to regulations set by international
guidelines [25] and the local Biosafety Committee. Mouse
embryonic fibroblasts (MEF) isolated from C57Black6 mice were
transduced with retroviral vectors containing the human cDNAs of
Oct4, Sox2, Klf4 and c-Myc inserted into moloney-based
retroviral vectors (pMXs). 293T cells [26] (kindly provided by
Dr. Bryan Strauss from Instituto do Corac ¸a ˜o, INCOR, Uni-
versidade de Sa ˜o Paulo) were used as packaging cells to the virus
production after calcium phosphate based transfection with the
following plasmids: pMXs (20 mg), pMDM (encoding mlv GAG/
POL, 10 mg) and pMD.G (encoding VSV G, 6 mg). The viral
supernatants were collected 48 and 72 h post-transfection, filtered
(0.22 mm) and concentrated at 32,000 g for 60 min. MEF were
exposed to two rounds of transduction with the 293T concentrated
supernatants. To improve transduction, polybrene (Sigma-Aldrich
Corp., St. Louis, USA) was used at 8 mg/ml and the plate was
centrifuged at 540 g for 45 min. Two days post-transduction, the
cells were cultured in iPS cells-medium (detailed below) and
treated with valproic acid (1 mM, Sigma-Aldrich Corp., St. Louis,
USA) for one week. Three days after transduction, 2.5610
5 cells
were plated on 2% gelatin-coated 35 mm plate with mitotically
inactivated MEF as feeders. Mouse ES cells-like colonies were
selected 15 days after the transduction. Valproic acid stock
solutions were made in phosphate buffered saline (PBS).
Cell culture
EC cells. P19 embryonal carcinoma cells [27] generously
donated by Dr. Michael McBurney from Ottawa Hospital
Research Institute (University of Ottawa) were cultured in
Dulbecco’s Modified Eagle’s Medium (DMEM) (Invitrogen, Life
Technologies, Carlsbad, USA) supplemented with 10% fetal
bovine serum (FBS) (Cultilab, Campinas, Brazil), 100 units/ml
penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine and
2 mM sodium pyruvate (all from Sigma-Aldrich Corp., St.
Louis, USA), in a humidified incubator at 5% CO2 and 37uC.
ES and iPS cells. E14TG2a mouse embryonic stem (ES) cells
[28,29] (kindly provided by Dr. Joshua Brickman from the
Institute for Stem Cell Research, MRC Centre for Regenerative
Medicine, University of Edinburgh) were grown on gelatin-coated
tissue culture dishes in Glasgow Minimum Essential Medium
(GMEM) (Cultilab, Campinas, Brazil) supplemented with 15%
FBS (Cultilab, Campinas, Brazil), 2 mM L-glutamine, 55 mM 2-
mercaptoethanol and 1% non-essential amino acids (all from
Invitrogen, Life Technologies, Carlsbad, USA). Mouse iPS cells
were cultured in high-glucose DMEM/F12 supplemented with
15% Knockout
TM Serum Replacement (KSR), 2 mM L-
glutamine, 55 mM 2-mercaptoethanol and 1% non-essential
amino acids (all from Invitrogen, Life Technologies, Carlsbad,
USA). Mitotically inactivated MEF were used as feeders for iPS
cells cultures. Conditioned medium (1:500) (v:v) from chinese
hamster ovary (CHO) cells carrying leukemia inhibitory factor
(LIF)-encoding vector was used as source of LIF for ES and iPS
cells maintenance. Cells were cultured in a humidified incubator at
5% CO2 and 37uC.
Since the use of enzymes (to obtain single-cell suspensions) may
affect the karyotype status of embryonic stem cells [30,31], we
have adopted manual dissection (which produces cell clumps,
instead of single-cells) to handle our cells and routinely monitored
them for karyotypic changes. While ES cells exhibited the same
number of chromosomes (40) after dozens of passages, iPS cells
presented a mixed population formed by cells with 40 or 41
chromosomes even after 3 passages, as similarly described for
human iPS cells [32].
Neural differentiation
EC cells. EC cells were differentiated into NPCs as previously
described [15,33,34]. Briefly, 5610
5 cells/ml were transferred to
non-adherent dishes to form embryoid bodies (EBs). EBs
developed in defined medium (DMEM supplemented with
2 mM L-glutamine, 2 mM sodium pyruvate, 2.4 mg/ml sodium
bicarbonate, 5 mg/ml insulin, 30 mg/ml human apo-transferrin,
20 mM ethanolamine, 30 nM sodium selenite, 100 U/ml
penicillin, 100 mg/ml streptomycin and 10 mM Hepes, pH 7.2)
supplemented with 1 mM all-trans retinoic acid (RA) (Sigma-
Aldrich Corp., St. Louis, USA) dissolved in dimethyl sulfoxide
(DMSO) (Sigma-Aldrich Corp., St. Louis, USA). After 2 days in
the presence of RA, EBs were collected and plated onto adherent
culture flasks with DMEM supplemented with 10% FBS for 48 h.
DMSO (0.8%) was used as vehicle.
ES and iPS cells. ES and iPS cells differentiation into NPCs
was carried out by RA treatment as previously described [35,36].
EBs were formed after transferring 2.5610
5 cells/ml to non-
adherent dishes. EBs were cultured in medium with FBS without
LIF. The percentage of FBS was 20% for ES-EBs and 15% for
iPS-EBs. After 4 days of formation, EBs were exposed to 5 mMR A
for additional 4 days. RA stock solution was prepared in DMSO,
which was also added to the control groups at the final
concentration of 0.01%. For immunofluorescence assays, EBs
after 8 days in vitro were dissociated in 0.05% trypsin/EDTA and
cells were plated onto precoated polyornithine (100 mg/ml, Sigma-
Aldrich Corp., St. Louis, USA) and laminin (5 mg/ml, Invitrogen,
Life Technologies, Carlsbad, USA) coverslips. After 2 h of plating,
immunofluorescence was performed as below.
For analysis of DNA content and neural immunophenotyping,
EBs exposed to RA or vehicle were dissociated as mentioned
above. Then, cells were plated at a density of 12610
5 cells/cm
2
onto polyornithine and laminin-coated plates and maintained in
neuronal medium, composed by high-glucose DMEM/F12
supplemented with 2% N2, 20 ng/ml fibroblast growth factor-2
(FGF-2) and 55 mM 2-mercaptoethanol (all from Invitrogen, Life
Technologies, Carlsbad, USA) for 5 days, then DNA analysis by
flow cytometry was carried out. For further analyses, EBs were
also plated into polyornithine and laminin substrates and
maintained in neuronal medium for 5 days.
Immunofluorescence
Cells were fixed with 4% paraformaldehyde in PBS for 20 min.
Blocking was achieved after 20 min of incubation with 3% bovine
serum albumin (BSA) combined with 0.1% Triton X-100 (Sigma-
Aldrich Corp., St. Louis, USA) in PBS. Cells were then incubated
for 2 h with primary antibodies diluted in PBS plus 0.1% Triton
X-100 and 3% BSA. Primary antibodies for nestin (Chemicon,
Millipore, Temecula, USA) and bIII-tubulin (Santa Cruz
Biotechnology, Santa Cruz, USA) were used. After rinsing with
PBS, anti-mouse Alexa 546-conjugated and anti-rabbit Alexa 488-
conjugated secondary antibodies (Life Technologies, Carlsbad,
USA) were added for 1 h, followed by 5 min incubation with
DAPI (49-6-diamidino-2-phenylindole). After rinsing with PBS,
coverslips were mounted on slides with Vectashield (Vector
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PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e20667Laboratories, Burlingame, USA) and examined on an Axiovert-
200 epifluorescence microscope (Carl Zeiss, Go ¨ttingen, Germany).
Chromosome counts
Metaphase spreads were prepared as previously described [37].
Cells were incubated with 0.1 mg/ml KaryoMAX colcemid (Gibco
Invitrogen, Life Technologies, Carlsbad, USA) for 6 h, then
dissociated using trypsin/EDTA 0.05% and incubated for 15 min
in a 75 mM KCl hypotonic solution at 37uC. The swollen cells
were fixed in a methanol/glacial acetic acid 3:1 (v:v) solution
(Merck KGaA, Darmstadt, Germany) and stored at 4uC
overnight. On the next day, cell suspension was washed with the
fixative solution and then spread onto glass slides. The slides were
quickly exposed to water steam to burst the cells. Chromosomes
were stained with DAPI, and the slides coverslipped with n-propyl
galate. The mounted slides were examined on a fluorescence
microscope (Nikon Eclipse 80i, Nikon Instruments Inc., NY,
USA). At least 60 metaphases were counted on each condition per
assay.
Once iPS cells present a mixed population formed by cells with
40 or 41 chromosomes, we adopted this interval as the modal
chromosome number for this cell line. Chromosome numbers
below and above range were considered as an increase in the
aneuploidy rate for iPS cells.
TUNEL assay
Apoptosis was determined in NPCs derived from EC cells using
an apoptosis detection kit (In Situ Cell Death Detection Kit,
Fluorescein; Roche Applied Science, Indianapolis, USA). After
harvesting, cells were fixed in 2% paraformaldehyde in PBS for
30 min at 4uC, rinsed with PBS and resuspended in 0.2% Triton-
X-100 and 0.2% Tween in PBS for 10 min at 4uC. Then, cells
were rinsed again with PBS and incubated with TUNEL reaction
mixture as suggested by the manufacturer. For negative controls,
instead of the TUNEL reaction mixture, cells were incubated with
label solution (without terminal transferase). For positive controls,
cells were incubated with DNase I (3 U/ml, Ambion, Austin, USA)
for 10 min at room temperature. Cells were analyzed by flow
cytometry (Beckman Coulter, Fc500) and data were analyzed
using the WinMDI 2.8 software available at http://facs.scripps.
edu/software.html. Thirty thousand events were acquired per
sample with fluorescence measured in logarithmic scales.
For apoptosis evaluation in NPCs derived from ES cells,
ApopTag Plus Fluorescein In Situ Apoptosis Detection Kit
(Chemicon, Temecula, USA) was used according to the manu-
facturer’s instructions. Briefly, EBs were dissociated and filtered
through a 40 mm nylon cell strainer (BD Biosciences, San Jose,
USA), cells were fixed in 1% paraformaldehyde in PBS for 15 min
at 4uC, rinsed in PBS and resuspended in 70% ice-cold ethanol for
at least 2 h. Then, cells were incubated with TdT enzyme and
anti-digoxigenin fluorescein conjugate. As negative control, cells
were not incubated with enzyme but with anti-digoxigenin
fluorescein. Cells were analyzed by flow cytometry (BD FACS-
Canto II, BD Biosciences, San Jose, USA) and data were analyzed
using the Summit software (Dako, Glostrup, Denmark). Twenty
thousand events were acquired per sample with fluorescence
measured in logarithmic scales.
Flow cytometric analysis of DNA content
The DNA content of NPCs derived from EC cells was
determined by flow cytometry. After harvesting, cells were fixed
in 70% ethanol at 220uC for at least 2 h. Then, cells were rinsed
twice with PBS, stained with propidium iodide (50 mg/ml, Sigma-
Aldrich Corp., St. Louis, USA) in the presence of RNase (100 mg/
ml, Ambion, Austin, USA) for 1 h at 37uC and taken to the
cytometer (Beckman Coulter, Fc500, Fullerton) for DNA content
analysis as previous described by Capparelli et al. [38]. Chick
erythrocyte nuclei (CEN) were used at one-tenth of sample
concentration as internal control. Thirty thousand events were
acquired per sample with fluorescence measured in logarithmic
scales. For determining changes in DNA content, relative DNA
content was expressed as the ratio of G0/G1 peak to the mean of
the CEN peak.
For analysis of DNA content within neuronal cells, RA treated-
EBs derived from ES cells, dissociated and plated for 5 days, were
fixed in ice-cold ethanol, rinsed with PBS and permeabilized with
0.5% Tween (Sigma-Aldrich Corp., St. Louis, USA) for 5 min. To
prevent nonspecific immunolabeling, 5% BSA was used for 1 h.
Then, samples were incubated on ice with primary antibody for
bIII-tubulin (Sigma-Aldrich Corp., St. Louis, USA) for 1 h. After
rinsing twice in PBS, anti-mouse Alexa 488-conjugated secondary
antibody (Life Technologies, Carlsbad, USA) was added for
30 min on ice. Following PBS washing, propidium iodide (PI) mix
consisting of 20 mg/ml PI (Sigma-Aldrich Corp., St. Louis, USA),
100 mg/ml RNase (Ambion, Austin, USA) and 0.1% Triton X-
100 (Sigma-Aldrich Corp., St. Louis, USA) diluted in PBS was
added and the cells were taken to the cytometer (BD FACSCanto
II, BD Biosciences, San Jose, USA). Mouse lymphocytes stained
under the same conditions were collected to calibrate the
cytometer regarding the position of G0/G1 peak. Fifty thousand
events were acquired per sample with fluorescence measured in
logarithmic scales. Relative DNA content between positive and
Figure 1. Neural differentiation in EC cells after RA treatment. EC, embryonal carcinoma cells; RA, all-trans retinoic acid.
doi:10.1371/journal.pone.0020667.g001
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intensity (MFI) of G0/G1 peak of positive cells in RA group to
MFI of G0/G1 peak of negative cells in vehicle group.
Micronuclei detection
For micronuclei detection, colonies of ES and iPS cells were
exposed to 5 mM RA for 4 days. Cytochalasin B (6 mg/ml, Sigma-
Aldrich Corp., St. Louis, USA) was added in the last 24 h of RA
treatment. Cells were dissociated and fixed in methanol/glacial
acetic acid 3:1 (v:v) (Merck KGaA, Darmstadt, Germany) solution,
then placed onto slides and stained with 10% Giemsa (Merck
KGaA, Darmstadt, Germany) diluted in distilled water (v:v) for
30 min. At least 2,000 nuclei were counted per sample at 1006
magnification. Differences in micronuclei fold change were
relative to cells treated with vehicle.
Quantitative RT-PCR
Total RNA was extracted from EBs after treatment with RA by
using Trizol (Invitrogen, Life Technologies, Carlsbad, USA).
DNAse I treatment (Apllied Biosystems, Life Technologies, Foster
City, USA) was applied and 1 mg of total RNA was reverse-
transcribed using cDNA Reverse Transcription Kit (Apllied
Biosystems, Life Technologies, Foster City, USA) according to the
manufacturer’s instructions. Quantitative RT-PCR was performed
using Power SYBRH Green PCR Master Mix (Apllied Biosystems,
Life Technologies, Foster City, USA) on the 7500 Real-Time PCR
System detector (Apllied Biosystems, LifeTechnologies, Foster City,
USA). RT-PCR was performed for 45 cycles with primers derived
from survivin (74 bp, 59-GGCTGGGAACCCGATGAC-39 and
59- CGGTTAGTTCTTCCATCTGCTTCT -39)a n db-actin
(85 bp, 59-CATCACTATTGGCAACGAGCG-39 and 59-ATG-
GATGCCACAGGATTCCA-39). All quantitative RT-PCR assays
were carried out in triplicates from three independent experiments.
Expression levels of individual transcripts were normalized to b-
actin expression and fold differences were calculated using the
2
2DDCt method.
Figure 2. Chromosomal instability increases after induction of
neural phenotype by RA in EC cells. (A) The rate of chromosomal
instability presented a 2-fold increase. The bars indicate mean 6 S.E.M.
of two independent assays, *p,0.05. (B) Analysis of relative DNA
content demonstrated that neural cells (RA) presented less DNA than
cells incubated with vehicle. RA, all-trans retinoic acid.
doi:10.1371/journal.pone.0020667.g002
Figure 3. Neural differentiation in ES and iPS cells after RA treatment. (A) Schematic representation of protocol. (B) Immunofluorescence
quantification confirmed commitment into neural progenitors (nestin) and young neurons (bIII-tubulin). The images correspond to ES-differentiated
cells. The bars indicate mean 6 S.E.M. of two independent assays, *p,0.05. ES, embryonic stem cells; iPS, induced pluripotent stem cells; RA, all-trans
retinoic acid.
doi:10.1371/journal.pone.0020667.g003
Neurogenesis In Vitro Is Accompanied by Aneuploidy
PLoS ONE | www.plosone.org 4 June 2011 | Volume 6 | Issue 6 | e20667Protein Extraction, SDS-PAGE and Western Blotting
Cell lysates were obtained with lysis buffer (1% NP-40, 0.25%
sodium deoxycholate, 50 mM Tris-HCl pH 7.4, 150 mM NaCl,
2 mM EDTA, 1 mM Na3VO4) supplemented with 16phospha-
tase and protease inhibitors (Sigma-Aldrich Corp., St. Louis,
USA). Cells were maintained in lysis buffer on ice and
homogenized by shaking at 5 min intervals until its complete
dissociation. Then, samples were centrifuged, the supernatants
recovered and protein quantity was measured by Bradford method
with albumin as standard. Forty mg of protein in sample buffer
were boiled for 3 min and separated by SDS-PAGE in a 15%
polyacrylamide gel at a constant voltage of 100 V. After
separation, proteins were transferred into a nitrocellulose mem-
brane (Hybond, Amersham, Piscataway, USA) in a semi-dry
system (Bio-Rad, Hercules, USA) for 120 min at constant
amperage of 0.1 mA.
For nonspecific blocking, 5% nonfat milk in tris-buffered saline
and 0.05% Tween-20 (TBS-T) was added for 2 h under agitation
at room temperature. After incubation with primary antibodies for
survivin (Sigma-Aldrich Corp., St. Louis, USA) or a-tubulin (Santa
Cruz Biotechnology, Santa Cruz, USA) overnight at 4uC,
membranes were washed and probed with anti-rabbit or anti-
mouse peroxidase-conjugated secondary antibodies (Invitrogen,
Life Technologies, Carlsbad, USA) for 2 h under agitation at
room temperature. Antibodies were diluted in 5% nonfat milk in
TBS-T. Then, membranes were washed in TBS-T. Blots were
revealed with SuperSignal West Pico (Pierce, Rockford, USA).
The resulting bands were measured with ImageJ software. The
values were expressed in arbitrary units while the survivin level
was plotted in relation to a-tubulin in the same lane. The
normalization was made considering vehicle as 1.
Statistical analysis
Results were expressed as mean 6 S.E.M. Analysis of statistical
significance was performed using 4.0 GraphPad Prism software.
Data were analyzed by unpaired t-test.
Results
Chromosome instability is increased in NPCs derived
from EC cells treated with RA
In order to investigate whether neural differentiation is
accompanied by aneuploidy in EC cells, EBs were formed and
concomitantly exposed to RA to trigger their differentiation into
NPCs (RA-NPCs). On day 4, immunofluorescence revealed nestin
and bIII-tubulin in, respectively, 96.462.3% and 94.363.6% of
Figure 4. RA induces aneuploidy increase in pluripotent stem cells but not in somatic cells. (A) Metaphase spreads of RA-NPCs derived
from ES cells stained with DAPI. After RA-neural differentiation, the aneuploidy level increased in (B) ES and (C) iPS cells, while (D) mouse embryonic
fibroblasts (MEF) exposed to RA did not present aneuploidy increase. The data refer to mean 6 S.E.M. of three independent experiments, *p,0.05. ES,
embryonic stem cells; iPS, induced pluripotent stem cells; NPCs, neural progenitor cells; RA, all-trans retinoic acid.
doi:10.1371/journal.pone.0020667.g004
Figure 5. Hypoploidy is the main kind of aneuploidy in RA-
NPCs. Upon (A) ES cells and (B) iPS cells differentiation with RA, the
hypoploidy level increased, whereas hyperploidy level was not altered.
The data refer to mean 6 S.E.M. of three independent experiments,
*p,0.05. ES, embryonic stem cells; iPS, induced pluripotent stem cells;
RA-NPCs, neural progenitor cells derived from all-trans retinoic acid
treatment.
doi:10.1371/journal.pone.0020667.g005
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(figure 1).
To identify changes in chromosome number, metaphases were
obtained from RA-NPCs and untreated cells. As previously
reported, EC cells possess massive genomic instability even in
the undifferentiated state [39]. Since we found that 89.060.6% of
undifferentiated EC cells presented between 59 and 65 chromo-
somes (data not shown), we considered this interval as the basal
level of chromosomal instability in this lineage. Chromosome
numbers below and above this range were considered as an
increase in aneuploidy for EC cells.
EC-derivedRA-NPCsdisplayeda2-foldincrease(44.560.6%)in
numerical chromosomal instability when compared to EC cells
incubated with vehicle (21.664.9%) (figure 2A). Moreover, analysis
of DNA content by flow cytometry revealed that RA-NPCs
displayed less DNA content than EC cells incubated with vehicle
(figure 2B), indicating loss of chromosomes after RA treatment.
Aneuploidy is increased in NPCs derived from ES and iPS
cells after treatment with RA
In order to evaluate whether RA also increases aneuploidy in
NPCs derived from chromosomal stable stem cells, NPCs were
derived from both ES and iPS cells.
Neural differentiation of ES and iPS cells was carried out as
previously described [35,36]. On day 8, nestin and bIII-tubulin
were present, respectively, in 62.760.1% and 29.061.6% in RA
primed ES cells and in 54.063.9% and 3662.1% in RA primed
iPS cells (figure 3).
Analysis of the chromosomal complement of RA-treated ES
cells (figure 4A) demonstrated that aneuploidy increased from
23.362.7% in cells incubated with vehicle only to 38.765.4% in
cells undergoing differentiation by RA (figure 4B). The same
phenomenon was demonstrated for RA-treated iPS cells, which
presented a 2-fold increase in the aneuploidy rate when compared
to cells incubated with vehicle (31.563.8% compared to
14.061.4%) (figure 4C). On the other hand, the parental MEF
with 40 chromosomes, from which our iPS cells were generated,
did not show any increase in aneuploidy rate when exposed to RA
under the same conditions as ES and iPS cells (5 mM RA for 4
days) (figure 4D).
Neural commitment with RA revealed that chromosome loss
(hypoploidy) was more prevalent than chromosome gain (hyper-
ploidy) in pluripotent stem cells. In ES-derived RA-NPCs,
33.164.6% of the cells were hypoploid compared to 12.762.0%
in cells incubated with vehicle, whereas the proportion of
hyperploidy was not increased by RA (10.562.4% in vehicle
compared to 5.661.5% in RA) (figure 5A). In iPS-derived RA-
NPCs, hypoploidy was again prevalent (29.864.2% in RA
compared to 7.360.4% in vehicle) while hyperploidy was not
increased by RA (6.761.0% in vehicle compared to 1.661.6% in
RA) (figure 5B). Table 1 shows the most common aneuploidies by
chromosome numberin RA-treated and untreated ESand iPScells.
In order to verify whether the RA-increased aneuploidy was
more prevalent in neural cells than in non-neural cells, we
evaluated DNA content by flow cytometry in cells expressing or
not bIII-tubulin. RA-treated EBs, dissociated and plated for 5
days, presented 47.066.4% of young neurons with long processes
expressing bIII-tubulin (figure 6A). To identify decreases in DNA
content, we assessed the PI mean fluorescence intensity (MFI).
Young neurons expressing bIII-tubulin presented less DNA
content than non-neural cells (figure 6B).
Table 1. Most common aneuploidies observed in pluripotent
stem cells after RA treatment.
Frequency (%)
ES iPS
Number of chromosomes Vehicle RA Vehicle RA
27 0,0 1,1 0,0 0,5
28 0,0 1,8 0,0 0,0
31 0,0 0,0 0,0 1,5
32 0,5 1,1 0,0 1,1
33 1,2 3,3 0,0 4,5
35 0,5 1,8 0,5 1,1
36 0,6 1,8 0,0 1,5
38 0,5 3,0 0,5 6,3
39 7,4 13,5 4,0 10,7
40 76,7 61,3 5,4 14,6
41 7,8 4,5 80,6 54,0
42 0,6 0,7 5,9 1,6
ES, embryonic stem cells; iPS, induced pluripotent stem cells; RA, all-trans
retinoic acid.
doi:10.1371/journal.pone.0020667.t001
Figure 6. After RA treatment ES-derived neural cells exhibit loss of DNA content. (A) RA-treated EBs plated for 5 days are enriched in bIII-
tubulin labeled young neurons forming a network with long processes. (B) Flow cytometry analysis of relative DNA content demonstrates decreased
DNA content in cells expressing bIII-tubulin compared to cells negative for this marker. Data was expressed as the ratio of propidium iodide mean
fluorescence intensity (MFI) of G0/G1 peak of positive cells in RA group to MFI of G0/G1 peak of unlabeled cells in vehicle group. The data refer to
mean 6 S.E.M. of four independent experiments, *p,0.1.
doi:10.1371/journal.pone.0020667.g006
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Next, we asked whether aneuploid RA-NPCs would be prone to
cell death. Both EC and ES cells undergoing neural differentiation
by RA were analyzed for DNA fragmentation. TUNEL technique
followed by flow cytometry demonstrated no difference in
apoptosis levels between RA-NPCs and cells incubated with
vehicle (figure 7A and B), demonstrating that an increase in
aneuploidy is not necessarily followed by cell death in RA-treated
stem cells.
Micronuclei formation is increased in pluripotent stem
cells after RA treatment
During mitosis, micronuclei can be formed when a chromosome
does not appropriately attach to the mitotic spindle and become
excluded from daughter cells nuclei. Micronucleus is an indicative
of mitotic checkpoint failure and a possible mechanism by which
aneuploidy emerges [40]. Our results revealed that RA-treated ES
cells presented micronuclei scoring 1.760.2 times higher than cells
incubated with the vehicle. In iPS cells, treatment with RA also
resulted in micronuclei increase (1.560.1 times higher than
vehicle) (figure 8).
Survivin expression is reduced in RA-treated embryonic
stem cells undergoing neurogenesis
Since a downregulation of survivin correlates with RA exposure
[41] and micronuclei formation in cancer cell lines [42], we
decided to investigate whether survivin expression could also be
reduced in embryonic stem cells undergoing neurogenesis after
treatment with RA. Quantitative real-time PCR (figure 9A) and
western blotting (figure 9B) analysis revealed that RA-treated cells
presented a 50% reduction in survivin mRNA and protein levels
when compared to untreated cells. These results indicate that a
member of the chromosomal passenger complex may be involved
in the mechanism by which RA increases aneuploidy and
micronuclei formation in pluripotent stem cells.
Discussion
It has been suggested that aneuploidy in the developing cerebral
cortex is the consequence of chromosome missegregation and
multipolar spindles [18,43]. Hypoploidy is the prevalent form of
aneuploidy observed during neurogenesis in vivo [18,19,20]. Here
we show that an increase in aneuploidy, especially chromosome
loss, is also observed in pluripotent stem cells undergoing
neurogenesis in vitro.
Recently, aneuploidy was described in neural progenitor cells
derived from the human fetal brain (hNPCs) after long-term cell
culture [44]. Sareen and colleagues reported that long-term
cultured hNPCs are susceptible to chromosome gains. They
observed that after 9 weeks and 25 weeks in vitro, five NPCs lines
and one NPC line, out of 21 cell lines, acquired trisomy 7 and
trisomy 19, respectively.
While Sareen et al. described chromosome gain upon selective
pressure in vitro, which emphasizes the need for careful cytogenetic
evaluation of NPCs before their use in clinical or basic science, our
data point to an increase in chromosome loss during neurogenesis
in vitro, similarly to the observed in vivo [18]. Moreover,
chromosome loss observed in pluripotent stem cells after retinoic
acid treatment occurs independently of the number of passages,
differently from Sareen et al., in which NPCs must be cultured for
at least 9 weeks to spontaneously generate chromosome gains.
A crucial question is whether aneuploidy here described was an
authentic characteristic of neural commitment of pluripotent stem
cells or a corollary effect of RA treatment. In this sense, MEF
exposed to the same concentration of RA for the same period of
time did not present numerical chromosome alterations. These
Figure 7. RA-treated stem cells do not necessarily undergo
apoptosis. No difference in apoptosis between RA-NPCs and cells
incubated with vehicle was observed in (A) EC cells or (B) ES cells. The
bars indicate mean 6 S.E.M. of three independent assays, *p,0.05. RA-
NPCs, neural progenitor cells derived from all-trans retinoic acid
treatment; EC, embryonal carcinoma cells; ES, embryonic stem cells.
doi:10.1371/journal.pone.0020667.g007
Figure 8. Micronuclei formation increase in pluripotent ES and iPS cells after RA exposure. (A) Photomicrography of two daughter cells
nuclei (arrowhead) and a micronucleus (arrow) detected by DAPI staining. (B) RA increased micronuclei formation in ES and iPS cells. Data was
expressed as the ratio of the mean of RA to the mean of vehicle. Bars indicate mean 6 S.E.M. of three independent assays, *p,0.05, #p,0.1. ES,
embryonic stem cells; iPS, induced pluripotent stem cells; RA, all-trans retinoic acid.
doi:10.1371/journal.pone.0020667.g008
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by RA is associated to neural differentiation; 2) somatic cells are
not prone to aneuploidy triggered by RA. In fact, embryonic stem
cells exhibit rapid cycles of cell division by bypassing certain
checkpoints [45,46,47], which is postulated to be a property of
stemness [48] but could also make these cells more prone to
aneuploidy.
It was previously reported that RA induces apoptosis in EC and
ES cells [49,50]. However, in both studies RA triggered apoptosis
immediately upon its exposure, which was attenuated after cells
start to differentiate [51]. In our case, apoptosis was measured in
embryoid bodies at least 2 days after RA treatment, when cells
were already committed to the neural fate. No difference in cell
death was detected, indicating that an increase in aneuploidy is not
directly associated with elimination of pluripotent stem cells
undergoing neural differentiation in vitro.
Another issue addressed in this work was the description of a
possible mechanism by which aneuploidy is triggered in
pluripotent stem cells after RA treatment. Micronuclei reflect an
inability to repair DNA lesions or deficits in checkpoints [40,52].
ES and iPS cells exposed to RA presented an increase in
micronuclei formation when compared to naı ¨ve cells. Consistently
Figure 9. Reduced survivin expression in RA-treated pluripotent stem cells. (A) Survivin mRNA and (B) survivin protein were significantly
reduced after RA treatment. For quantitative PCR, relative mRNA levels represent the amount of survivin mRNA compared to b-actin mRNA; for
western blotting, relative survivin levels are compared to a-tubulin. Bars indicate mean 6 S.E.M. of three independent assays, * p,0.1. Data were
expressed as the ratio of the mean of RA to the mean of vehicle.
doi:10.1371/journal.pone.0020667.g009
Figure 10. During neurogenesis, stem cells are prone to chromosome loss and micronuclei formation, which correlates with
survivin downregulation. Neural aneuploidy may contribute to cell diversity within the CNS. CNS, central nervous system.
doi:10.1371/journal.pone.0020667.g010
Neurogenesis In Vitro Is Accompanied by Aneuploidy
PLoS ONE | www.plosone.org 8 June 2011 | Volume 6 | Issue 6 | e20667with our findings, Yang and coworkers reported micronucleation
in NPCs in vivo [43]. It is worth mentioning that NPCs derived
from the developing cerebral cortex show tolerance to chromo-
somal instability associated with an inefficient checkpoint mech-
anism [53], similarly to the observed in pluripotent stem cells [48].
Interestingly, the expression of survivin, which exerts multiple
roles in chromosome segregation [54,55], was reduced in
embryonic stem cells after RA treatment.
It is well known that the depletion of survivin, functioning as
tension-sensor at kinetochores-microtubules interactions in mitotic
checkpoint [54], leads to unaligned chromosomes, failure in the
mitotic checkpoint arrest [56] and inaccurate chromosome
segregation [57,58]. Indeed, in breast cancer cell lines, Pratt et
al. demonstrated reduced expression of survivin in response to RA
[41], while delayed expression of survivin results in cancer cells
with micronuclei [42].
These data provide evidence that somatically generated
chromosomal variation accompanies neurogenesis. We suggest
that pluripotent stem cells undergoing neural differentiation are
prone to mitotic checkpoint failure and defects in kinetochores-
microtubules attachment, as indicated by the reduction in survivin
expression, culminating with micronuclei formation and aneu-
ploidy (figure 10). We cannot assure if aneuploidy is a cause or a
consequence of neural differentiation but our results indicate that
loss of entire chromosomes is a common feature of neurogenesis
induced in vitro, which may lead to altered gene expression [20].
These results support the idea that aneuploidy is a common
feature of neural progenitor cells both in vivo and in vitro and may
play a crucial role in neurogenesis. Nevertheless, alternative
protocols, without using RA, to induce neural differentiation
should be applied to characterize a broader association between
aneuploidy and neurogenesis. To our knowledge this is the first
demonstration that aneuploidy and micronuclei are amplified
during neurogenesis induced by RA in pluripotent stem cells. The
physiological consequences of neurogenic aneuploidy should be
carefully considered before exploring the full potential of neural
cells derived in vitro towards therapy for neurodegenerative
diseases.
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